LIVE
A research blend co-dosing retatrutide (a triple GLP-1 / GIP / glucagon receptor agonist) with tirzepatide (a dual GLP-1 / GIP agonist). Both molecules are Eli Lilly incretin-class therapeutics in advanced obesity trials; vendor-offered blends combine them for co-administration in research settings, though no commercial clinical combination product exists.
For research purposes only. Not medical advice.
Glow Aminos currently lists Retatrutide + Tirzepatide Blend at $2.84/mg, the lowest indexed price across 3 tracked research peptide vendors.
Retatrutide + Tirzepatide Blend ranges from $2.84/mg to $5.69/mg across 3 listings from 3 research peptide vendors, normalized to USD per milligram and refreshed daily.
3 research peptide vendors currently list Retatrutide + Tirzepatide Blend on PeptideScouter. We track 3 active listings across size and kit variants.
